Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Efficacy Comparison of Escitalopram and Citalopram in the Treatment of Major Depressive Disorder: Pooled Analysis of Placebo-Controlled Trials
1
x
$
0.00
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder
1
x
$
0.00
Serum Concentration of Paliperidone Palmitate Administered Every 3 Weeks
1
x
$
30.00
Treatment of Posttraumatic Stress Disorder: The Impact of Paroxetine
1
x
$
30.00
The Case for Geriatric Oncology
1
x
$
0.00
Effects of Discontinuation of Paliperidone Long-Acting Injectable After Switching from Risperidone Long-Acting Injectable Switching
1
x
$
30.00
Sin prisa y sin pausa: el estimado maestro Dr. Javier Mariátegui Chiappe
1
x
$
0.00
James H. Kocsis, MD: Continuation Treatment of Chronic Depression: A Comparison of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination
1
x
$
30.00
Combined Antipsychotics and Electroconvulsive Therapy in an Acutely Psychotic Patient with Treatment-Resistant Schizophrenia
1
x
$
30.00
Boadie W. Dunlop, MD: Disturbed Glucose Metabolism Among Patients Taking Olanzapine and Typical Antipsychotics
1
x
$
30.00
Treatment of Parental Depression and Reduced Risk in Offspring-Does It Have Anything to Do with Offspring Gender?
1
x
$
30.00
The Development of Single-Isomer Molecules: Why and How
1
x
$
0.00
E. Chris Muly, MD, PhD: Signal Transduction Abnormalities in Schizophrenia: the cAMP System
1
x
$
30.00
Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania
1
x
$
30.00
Economic Impacts of Anxiety Disorders
1
x
$
0.00
Cannabis Use and its Association with Psychological Disorders
1
x
$
30.00
View Cart
Checkout
Home
Store
“Cannabis Use and its Association with Psychological Disorders” has been added to your cart.
View cart
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Successful Management of Psychotropics Induced Stuttering Priapism with Pseudoephedrine in a Patient with Schizophrenia
$
30.00
Add to cart
Details
John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment
$
30.00
Add to cart
Details
A Case of Clozapine Induced Mania-Like Symptoms in the Treatment of Schizophrenia
$
30.00
Add to cart
Details
A Bell’s Palsy Case Probably Related to Sertraline Use
$
30.00
Add to cart
Details
The Prescriber’s Guide to the MAOI Diet—Thinking Through Tyramine Troubles
$
30.00
Add to cart
Details
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 46 No. 1 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
A Systematic Review of Augmentation Strategies for Major Depressive Disorder
$
30.00
Add to cart
Details
The Black Book of Psychotropic Dosing and Monitoring
$
30.00
Add to cart
Details
Adjunctive Pimavanserin in Patients with Major Depressive Disorder: Combined Results from Two Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
$
30.00
Add to cart
Details
Lumateperone for the Treatment of Schizophrenia
$
30.00
Add to cart
Details
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
$
30.00
Add to cart
Details
A Placebo-Controlled Trial of Guanfacine for the Treatment of Posttraumatic Stress Disorder in Veterans
$
30.00
Add to cart
Details
Successful Add-on Viloxazine to Clozapine-Responsive Schizophrenia Mitigated Cognitive, Negative and Metabolic Domains
$
30.00
Add to cart
Details
Sequential Multiple Assignment Randomized Treatment (SMART) for Bipolar Disorder at Any Phase of Illness and at least Mild Symptom Severity
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 37 Supplement No. 2 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
A Failed 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of Once-Daily Extended Release Quetiapine Fumarate in Patients with Acute Schizophrenia: Lessons Learned
$
30.00
Add to cart
Details
Raised Creatine Kinase with Numerous Antipsychotics Responded to Clozapine
$
30.00
Add to cart
Details
Early Positive Report of Viloxazine for a Child with Hyperkinetic Autism
$
30.00
Add to cart
Details
Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with Schizophrenia
$
30.00
Add to cart
Details
Previous
1
2
3
4
…
44
Next
Page load link
Go to Top
